Saundra Pelletier Email

CEO . Evofem Biosciences

Current Roles

Employees:
190
Revenue:
$29.4M
About
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem Biosciences exists to advance the lives of women by developing innovative solutions, such as woman-controlled contraception and potential protection from certain sexually transmitted infections (STIs). The Company is leveraging its proprietary Multi-purpose Vaginal pH Regulator™ (MVP-R) platform to develop Amphora, which if approved will be the first on-demand and female controlled MVP-R birth control method in the U.S.
Evofem Biosciences Address
7770 Regents Rd
San Diego, CA
United States
Evofem Biosciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.